Treatment of metastatic tumors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9603952
APP PUB NO 20150374860A1
SERIAL NO

14702934

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to methods and methods for the treatment, inhibition and/or reduction, and detection of metastatic tumors. In some embodiments, the inventive methods include systemic (e.g., intravenous) administration of a chlorotoxin agent that may or may not be labeled. In some embodiments, the inventive methods allow treatment, inhibition and/or reduction, and detection of metastases in the brain. In some embodiments, neovascularization is inhibited and/or newly formed vessels are caused to regress.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MORPHOTEK, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Egan, E Michael Brookline, US 6 109
Jacoby, Douglas B Wellesley, US 16 269
Kesavan, Kamala West Roxbury, US 4 79
O'Neill, Alison Cambridge, US 8 90
Sentissi, Abdellah Dover, US 13 190

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 28, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00